Moderna：mRNA的巨大不对称性！(NASDAQ:MRNA)
· seekingalpha.com
Moderna的上涨空间取决于Intismeran在多种肿瘤类型中的扩展能力，而不仅仅是黑色素瘤。了解为何MRNA股票是强力买入。
On August 19, Merck and Moderna ( MRNA ) announced that their phase 3 melanoma study had met both of its efficacy endpoints. Although we do not have the actual ...